A Clinical Study on Levosimendan Improvement of Prognosis of ARDS Patients by Optimizing Pulmonary Hemodynamics
Status:
Recruiting
Trial end date:
2022-08-30
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the curative effect of Levosimendan on ARDS
patients through omni-directional and multi-angle objective quantitative indexes, and to
study the responsiveness of ARDS with or without right ventricular insufficiency to the
treatment of Levosimendan, and to indirectly confirm whether Levosimendan had lung protective
mechanism other than calcium sensitization to ARDS patients, such as inhibiting inflammatory
reaction to reduce pulmonary capillary leakage and alveolar epithelial cell injury.
Relaxation of bronchial smooth muscle improves pulmonary ventilation function. To provide new
methods and ideas for clinical treatment of ARDS.